The 6.25% Health Care Protect Reverse Convertible Bond combines twofixed interest payments of 6.25% with a partial safety mechanism for the invested capital down to the barrier. The interest amount is paid out annually, regardless of the performance of the three underlying shares (Bayer AG, Sanofi S.A., Koninklijke Philips N.V.).
The reverse convertible bond is redeemed at 100% of the nominal value at the maturity date (July 2019), provided that the daily closing price of each of the three underlying shares is always above the respective barrier of 59% during the observation period (daily observation).
In case one of the barriers is touched or undercut by the daily closing price of at least one of the underlying shares and at least one of these shares closes below its strike at the final valuation date, the predefined amount of the worst performing share is delivered (percentage performance from the starting value to the closing price at the final valuation date).
Key Facts:
- ISIN: AT0000A1WB88
- Initial valuation date: Jul 11, 2017
- Observation period: Jul 12, 2017 – Jul 9, 2019
- Term: 2 years (maturity date: Jul 12, 2019)
- Public offer in: Austria, Germany, Italy, Hungary, Poland, Czechia, Slovakia, Romania, Slovenia, Croatia
- Listing: Vienna, Frankfurt, Stuttgart
For any additional information you may require do not hesitate to contact us on +43151520484.
The Structured Products Team of Raiffeisen Centrobank
The product described herein is subject to and governed by the Base Prospectus (including all supplements and amendments thereto) approved by the Austrian Financial Market Authority. The Base Prospectus is deposited at Oesterreichische Kontrollbank AG, published on www.rcb.at/SecuritiesProspectus and contains the risks and Terms and Conditions of the product.
Raiffeisen Centrobank AG is subject to supervision by the FMA and the Oesterreichische Nationalbank as well as the ECB, the latter within the Single Supervisory Mechanism (Council Regulation (EU) No 1024/2013).
